BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17018398)

  • 1. Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia.
    Smolej L; Andrys C; Peková S; Schwarz J; Belada D; Zák P
    Haematologica; 2006 Oct; 91(10):1432-3. PubMed ID: 17018398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutated or non-mutated? Which database to choose when determining the IgVH hypermutation status in chronic lymphocytic leukemia?
    Peková S; Baran-Marszak F; Schwarz J; Matoska V
    Haematologica; 2006 Mar; 91(3):ELT01. PubMed ID: 16533734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgVH mutation status in patients with chronic lymphocytic leukemia].
    Zhang YP; Chen LJ; Zheng WJ; Wu YJ; Qiu HX; Qian SX; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):164-7. PubMed ID: 18788614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia.
    Pasqualucci L; Neri A; Baldini L; Dalla-Favera R; Migliazza A
    Cancer Res; 2000 Oct; 60(20):5644-8. PubMed ID: 11059755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia.
    Fink SR; Paternoster SF; Smoley SA; Flynn HC; Geyer SM; Shanafelt TD; Lee YK; Jelinek DF; Kay NE; Dewald GW
    Leuk Res; 2005 Mar; 29(3):253-62. PubMed ID: 15661260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Karyotype complexity and VH gene status in B-cell chronic lymphocytic leukemia.
    Méhes G; Kovács G; Kajtár B; Lacza A; Várnai A; Losonczy H; Pajor L
    Haematologica; 2006 Oct; 91(10):1430-1. PubMed ID: 16963400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia.
    Koiso H; Yamane A; Mitsui T; Matsushima T; Tsukamoto N; Murakami H; Miyawaki S; Nojima Y; Karasawa M
    Leuk Res; 2006 Mar; 30(3):272-6. PubMed ID: 16159662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgVH mutations in patients with chronic lymphocytic leukemia.
    Foà R
    Haematologica; 2005 Apr; 90(4):434-5. PubMed ID: 15820928
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow.
    van Gent R; Kater AP; Otto SA; Jaspers A; Borghans JA; Vrisekoop N; Ackermans MA; Ruiter AF; Wittebol S; Eldering E; van Oers MH; Tesselaar K; Kersten MJ; Miedema F
    Cancer Res; 2008 Dec; 68(24):10137-44. PubMed ID: 19074880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
    Degan M; Bomben R; Bo MD; Zucchetto A; Nanni P; Rupolo M; Steffan A; Attadia V; Ballerini PF; Damiani D; Pucillo C; Poeta GD; Colombatti A; Gattei V
    Br J Haematol; 2004 Jul; 126(1):29-42. PubMed ID: 15198729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia.
    Chen YH; Peterson LC; Dittmann D; Evens A; Rosen S; Khoong A; Shankey TV; Forman M; Gupta R; Goolsby CL
    Am J Clin Pathol; 2007 Feb; 127(2):182-91. PubMed ID: 17210531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.
    Molica S; Cutrona G; Vitelli G; Mirabelli R; Molica M; Digiesi G; Ribatti D; Ferrarini M; Vacca A
    Leuk Res; 2007 Nov; 31(11):1575-8. PubMed ID: 17485110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
    Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.
    Ma W; Kantarjian H; O'Brien S; Jilani I; Zhang X; Estrov Z; Ferrajoli A; Keating M; Giles F; Albitar M
    Cancer; 2008 Mar; 112(6):1306-12. PubMed ID: 18224667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.